An advisory panel to the FDA will be asked to vote next week on whether Jardiance (empagliflozin) from Eli Lilly...
Racism and implicit bias in healthcare systems continue to have negative effects on the patient experience and treatment outcomes of Black women.
Review of Australia authorising use of MDMA and psilocybin for depression and PTSD, clinical data behind authorisation, and related concerns.
The clinical course of autosomal dominant polycystic kidney disease (ADPKD) starts in childhood. Evidence of the beneficial impact of early nephron-protective strategies and lifestyle modifications on ADPKD prognosis is accumulating.